📉 Bearish
Bittensor’s SN68 subnet accelerates drug R&D at Metanova Labs
Summary
Decentralized AI in drug R&D could democratize discovery, reduce costs, and challenge traditional pharma, but validation hurdles remain. The post Bittensor’s SN68 subnet accelerates drug R&D at Metanova Labs appeared first on Crypto Briefing.
Original article published on
This article summarises third-party news content. Blokaro is not the original publisher. We link directly to the source and make no editorial claims about this article's content. Not financial advice. Report an issue →